Dror Ortho-Design posted a net loss of USD 1.26 million for the six months ended June 30, 2026, versus USD 1.34 million a year earlier.
Cash used in operations narrowed 28% to USD 709,019, leaving cash of USD 93,563 at June 30, 2026.
Research and development expense fell 52% to USD 269,179, due to decreased activities relating to software development.
Debt discount amortization more than doubled to USD 236,787, reflecting a higher amount of debt instruments issued after June 30, 2025.
The company had no revenue, flagged substantial doubt about going concern, and reiterated plans to spend about USD 1.5 million over 18 months on development and regulatory work.
DROR•
